Dapsone-induced artifactual A1c reduction in islet transplant recipients [1]

Transplantation

Volumn 83, Issue 6, 2007, Pages 824-825

  Froud, Tatiana ^a   Faradji, Raquel N ^a   Gorn, Lisa ^a   Monroy, Kathy ^a   Paz, Charlotte ^a   Baidal, David A ^a   Ponte, Gaston ^a   Cure, Pablo ^a   Poggioli, Raffaella ^a   Pileggi, Antonello ^a   Ricordi, Camillo ^a   Alejandro, Rodolfo ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DAPSONE; GLUCOSE; HEMOGLOBIN A1C;

ANEMIA; BONE MARROW SUPPRESSION; CORRELATION ANALYSIS; DRUG EFFICACY; ERYTHROCYTE; GLYCEMIC CONTROL; GRAFT RECIPIENT; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; METHEMOGLOBINEMIA; OXIDATION; PANCREAS ISLET TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETICULOCYTOSIS; SIDE EFFECT; TREATMENT DURATION;

DAPSONE; DIABETES MELLITUS, TYPE 1; FALSE POSITIVE REACTIONS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 34147149716     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000257918.71325.07     Document Type: Letter

References (10)

1. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037.
2. Johnson RN, Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 1983; 127: 87.
3. Smith RS, Alexander S. Heinz-body anaemia due to dapsone. BMJ 1959; 15: 625.
4. Bertholon M, Mayer A, Francina A, Thivolet CH. Interference of dapsone in HbA1c monitoring of a type I diabetic patient with necrobiosis lipoidica. Diabetes Care 1994; 17: 1364.
5. Tack CJ, Wetzels JF. Decreased HbA1c levels due to sulfonamide-induced hemolysis in two IDDM patients. Diabetes Care 1996; 19: 775.
6. Peterson CM, Ahkavan M, Fernandez-Soto ML, et al. Dapsone at onset of diabetes lowers glycated hemoglobin and delays death in NOD mice. Autoimmunity 1998; 28: 157.
7. Serratrice J, Granel B, Swiader L, et al. Interference of dapsone in HbA1c monitoring of a diabetic patient with polychondritis. Diabetes Metab 2002; 28: 508.
8. Albright ES, Ovalle F, Bell DS. Artificially low hemoglobin A1c caused by use of dapsone. Endocr Pract 2002; 8: 370.
9. Hafiz MM, Faradji RN, Froud T, et al. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation 2005; 80: 1718.
10. Smith RJ, Koenig RJ, Binnerts A, et al. Regulation of hemoglobin a1c formation in human erythrocytes in vitro. effects of physiologic factors other than glucose. J Clin Invest 1982; 69: 1164.